Dolutegravir
Back to searchMolecule Structure
Scientific Name
Dolutegravir
Description of the Drug
Dolutegravir is an antiviral agent used for the treatment of HIV-1 infections in combination with other antiretroviral agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08930
http://www.drugbank.ca/drugs/DB08930
Brand Name(s)
Tivicay
Company Owner(s)
Viiv Healthcare Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 integrase | SINGLE PROTEIN | INHIBITOR | CHEMBL3471 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL82071 | ||
| PharmGKB | PA166114961 | ||
| DrugBank | DB08930 | ||
| PubChem: Thomson Pharma | 96100998 | ||
| PubChem | 54726191 | ||
| Nikkaji | J3.008.741K | ||
| PDBe | DLU | ||
| BindingDB | 50062551 | ||
| DrugCentral | 4805 | ||
| Brenda | 230559 | ||
| ChemicalBook | CB62538916 | ||
| Guide to Pharmacology | 7365 | ||
| rxnorm | TIVICAY | DOLUTEGRAVIR SODIUM | DOLUTEGRAVIR |
| PubChem: Drugs of the Future | 123055423 | ||
| ChEBI | 76010 | ||
| ZINC | ZINC000058581064 |
